HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats.

Abstract
The differential roles of circulating and intrarenal renin-angiotensin system (RAS) in glomerulonephritis have not been elucidated. In this study, we investigated the levels of circulating and intrarenal RAS activity and urinary angiotensinogen (AGT) excretion in anti-thymocyte serum (ATS) nephritis induced by an ATS injection (ATS group). The effect of olmesartan, an angiotensin II (ANG II) type 1 receptor blocker (ARB), on the development of nephritis was also examined (ATS+ARB group). In addition, the rats received a saline injection instead of ATS (control group). Mesangial proliferation with transient proteinuria, which peaked at day 7, was significantly increased in the ATS group compared with the control group. The levels of glomerular AGT mRNA, intrarenal ANG II, and urinary AGT excretion in the ATS group were increased significantly at day 7 compared with the control group. Administration of olmesartan (ATS+ARB group) significantly decreased the levels of renal lesions, proteinuria, and intrarenal RAS activity compared with the ATS group. In addition, the levels of urinary AGT excretion correlated with the levels of glomerular damage, urinary protein excretion, and immunoreactivity for AGT and ANG II in kidney. On the other hand, plasma renin activity was significantly lower in the ATS group compared with the control group and significantly higher in the ATS+ARB group than in the ATS group. These data suggest that an increase in kidney-specific RAS activity, which parallels urinary AGT excretion, plays an important role in the development of ATS nephritis.
AuthorsNaro Ohashi, Tatsuo Yamamoto, Yanjie Huang, Taro Misaki, Hirotaka Fukasawa, Hiroyuki Suzuki, Akashi Togawa, Sayuri Suzuki, Yoshihide Fujigaki, Tsutomu Nakagawa, Yukio Nakamura, Fumiaki Suzuki, Masatoshi Kitagawa, Akira Hishida
JournalAmerican journal of physiology. Renal physiology (Am J Physiol Renal Physiol) Vol. 295 Issue 5 Pg. F1512-8 (Nov 2008) ISSN: 1931-857X [Print] United States
PMID18784264 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiotensin II Type 1 Receptor Blockers
  • Antilymphocyte Serum
  • Imidazoles
  • RNA, Messenger
  • Tetrazoles
  • Angiotensinogen
  • Angiotensin II
  • olmesartan
  • Renin
Topics
  • Angiotensin II (blood, metabolism)
  • Angiotensin II Type 1 Receptor Blockers (pharmacology)
  • Angiotensinogen (genetics, metabolism, urine)
  • Animals
  • Antilymphocyte Serum (pharmacology)
  • Blood Pressure (physiology)
  • Gene Expression (drug effects)
  • Glomerulonephritis, Membranoproliferative (pathology, physiopathology, urine)
  • Imidazoles (pharmacology)
  • Kidney (drug effects, metabolism, pathology)
  • Male
  • Proteinuria (urine)
  • RNA, Messenger (genetics, metabolism)
  • Rats
  • Rats, Wistar
  • Renin (blood)
  • Renin-Angiotensin System (physiology)
  • Tetrazoles (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: